Goldiam International Secures Export Orders for Lab-Grown Jewellery

The Mumbai-based manufacturer continues to strengthen its global presence, securing fresh export contracts for its lab-grown diamond jewellery line.

MUMBAI — Goldiam International Limited has reinforced its position in the sustainable luxury market by securing new export purchase orders worth ₹60 crore for the manufacturing and export of lab-grown diamond-studded gold jewellery. These orders, sourced from international clients in the United States, are scheduled to be executed on or before August 30, 2026.

This development marks a significant milestone in the company’s ongoing transition from traditional natural diamond jewellery toward a lab-grown diamond (LGD) centric model. As of recent disclosures, this LGD segment constitutes over 90% of the company's total sales mix, highlighting a successful strategic pivot for the Mumbai-based exporter.

Strategic Shift and Market Momentum

Goldiam International has been aggressively expanding its footprint in the lab-grown diamond space, leveraging its backward-integrated manufacturing capabilities to maintain competitive margins. Unlike traditional diamond jewellery exporters, Goldiam’s emphasis on in-house LGD production has allowed it to navigate market volatility while maintaining a net-debt-free balance sheet.

The company’s management has indicated that these export orders, which exclude their online business channel, provide strong revenue visibility heading into the second half of the year. The US market remains the primary destination for Goldiam’s exports, a relationship that has been solidified over three decades of wholesale and retail partnerships.

Corporate Actions and Retail Growth

In addition to its export success, Goldiam International has recently garnered investor attention through proactive corporate actions. On July 10, 2026, the company’s shares traded ex-bonus following a 1:3 bonus equity share issue, an event that led to a notable surge in trading volumes as investors reacted to the firm's capital distribution strategy.

Simultaneously, the company is scaling its domestic B2C presence. Its dedicated retail brand, "ORIGEM," which focuses exclusively on lab-grown diamond jewellery, has expanded its reach with 25 operational store locations as of June 2026. This dual-track growth engine—combining high-volume international B2B exports with an expanding domestic retail network—forms the core of Goldiam’s current expansion strategy.

Official Sources

According to company filings submitted to the National Stock Exchange (NSE) and BSE Limited, the ₹60 crore order win was officially announced on May 11, 2026. Goldiam International clarified in its regulatory communications that the contracts are not related-party transactions and that neither the promoters nor the promoter group entities have any interest in the awarding entities.

Why It Matters

For investors and stakeholders, this order win serves as a validation of the continued demand for lab-grown diamonds in the US retail sector. As global consumer preferences shift toward sustainable and affordably priced luxury items, Goldiam’s ability to secure large-scale contracts reinforces its operational resilience. The company's focus on high-margin products and its "net-debt-free" status are viewed by analysts as key stabilizers in an otherwise competitive and price-sensitive jewellery market.

Key Facts at a Glance

• Order Value: ₹60 crore for lab-grown diamond-studded gold jewellery.

• Target Market: United States.

• Execution Deadline: On or before August 30, 2026.

• Product Focus: Lab-grown diamonds, which now account for >90% of the company's revenue mix.

• Corporate Milestone: Successfully completed a 1:3 bonus share issue in July 2026.

Frequently Asked Questions (FAQ)

What does the recent ₹60 crore export order entail? The order involves the manufacturing and export of lab-grown diamond-studded gold jewellery for clients in the United States, to be completed by August 30, 2026.

How significant is the lab-grown diamond segment for Goldiam? Lab-grown diamonds have become the company's primary focus, currently contributing over 90% of its total revenue mix, a significant shift from its traditional natural diamond business.

Did the recent bonus share issue affect the stock price? Yes, Goldiam International’s stock traded ex-bonus on July 10, 2026. The share price adjusted proportionally to the 1:3 bonus ratio, with the company seeing strong trading volumes following the announcement.

What is the "ORIGEM" brand? ORIGEM is Goldiam International’s dedicated domestic retail brand, which focuses exclusively on offering lab-grown diamond jewellery to Indian consumers through an expanding chain of physical stores.

Source: Goldiam International NSE Regulatory Filings, BSE India Corporate Announcements, Capital Market News